TOP HEADLINES

Featured Story

Blaze wins NCI funding for 'tumor paint' after successful dog study

Blaze Bioscience has nabbed a $1.5 million Small Business Innovation Research (SBIR) Phase II award from the National Cancer Institute (NCI) to continue researching its product, called Tumor Paint BLZ-100, which will be studied in people with soft tissue sarcoma. The company was awarded the funding based on the successful completion of a trial in 27 pet dogs with various tumor types.

Canadian government funds Elanco genomics project

The Canadian government is pouring $56 million into 12 projects aimed at translating genomic discoveries into marketable products, including several in the animal health industry. The initiative aims to link up academic institutions with users of genomic research, including drug companies, nonprofit agencies, and government bodies.

Phibro continues to win over investors 6 months after IPO

Even in the midst of a rocky week on the public markets, shares of Wall Street newcomer Phibro Animal Health continued to ride a wave of positive analyst notes and overall investor enthusiasm for the animal health industry.

EU official: Boar hunting should stop until African swine fever vax is developed

Hunting of infected boars is being blamed for the spread of African swine fever in Poland, Estonia, Latvia and Lithuania, according to a top European Commission animal health official, who also rebuffed claims the agency isn't doing enough to fight the virus.

Chronic wasting disease found in Iowa captive deer population

Chronic wasting disease was found in a captive deer population in north-central Iowa, the state's Department of Agriculture and Land Stewardship said.

MORE NEWS

From Our Sister Sites

FiercePharma

Moncef Slaoui With a three-part, multi-billion dollar transaction with Novartis set to close next year, changes are on the way for GlaxoSmithKline--and, fittingly, for its top management...

FierceDrugDelivery

Portal Instruments, a new Boston-based company, secured $11 million for its computerized needle-free drug delivery system via a Series A funding round led by Sanofi, Boston-based VC PBJ Capital and a major medical device company. It became only the third company to receive funding under Sanofi's Sunrise Initiative for early stage companies.